Glenmark Pharma Gets U.S. FDA Warning Letter Over Baddi Unit
Glenmark Pharmaceuticals Ltd. received a warning letter from the U.S. Food and Drug Administration for its Baddi facility in Himachal Pradesh.
The company is committed to working along with the regulator to implement all the necessary corrective actions required to address the concerns raised in the letter, the Glenn Saldanha-led company said in an exchange filing, adding that it does not see any financial impact on account of the development.
We believe that the existing manufacturing and the sale of products from this facility will not be impacted. There are no major pending approvals from this facility in the next 12 months.Glenmark Pharmaceuticals' Exchange Filing
The company, however, added that the Baddi facility is expected to contribute $30 million in total sales this financial year, or approximately 7 percent of total U.S. sales.
The FDA warning letter could lead to lower volume and revenue contribution from exports to the U.S. in the ongoing financial year, as the focus will be on remediation work, Prabhudas Lilladher analyst Surjit Pal to BloombergQuint. “Besides additional caution before sending batches to the U.S. will also slow down production.”
Glenmark Pharmaceuticals mainly produces oral solids, liquids, lotions, and ointments for skin and respiratory ailments at the Baddi unit.
The warning letter followed an FDA inspection of the facility between April 15 and April 20, after which the regulator issued a Form 483 with eight observations.
The company said that it is in the process of preparing a detailed response to the FDA within 15 working days.
The company has eight manufacturing plants - five formulations units and three Active Pharmaceutical Ingredient facilities - approved by the FDA, and none of these units except Baddi has any outstanding issues, the Mumbai-based company said.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.